World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
13158
World Ranking
3239
National Ranking
1514

Paul A. Offit publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Paul A. Offit sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 215 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Paul A. Offit D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Paul A. Offit sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2018 - Albert B. Sabin Gold Medal, Sabin Vaccine Institute
  • 2015 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 2015 - Fellow of the American Academy of Arts and Sciences
  • 2013 - Maxwell Finland Award for Scientific Achievement, National Foundation for Infectious Diseases
  • 2011 - Member of the National Academy of Medicine (NAM)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Paul A. Offit is affiliated with the Children's Hospital of Philadelphia in the United States. Their research primarily spans the fields of Medicine and Social Sciences, with significant contributions to Infectious Diseases, Health, and Epidemiology. Their work also intersects with Obstetrics and Gynecology as well as Animal Science and Zoology.

The scientist's main topics of study include Vaccine Coverage and Hesitancy, SARS-CoV-2 and COVID-19 Research, and Viral Gastroenteritis Research and Epidemiology. Other areas of focus are COVID-19 Impact on Reproduction, Animal Virus Infections Studies, COVID-19 Clinical Research Studies, and Influenza Virus Research Studies.

Paul A. Offit's frequently published venues include Vaccine, JAMA, New England Journal of Medicine, Science, and Annals of Allergy Asthma & Immunology.

Recent papers feature a range of contributions to vaccine and COVID-19-related research:

  • Vaccine Safety: Myths and Misinformation, 2020, Frontiers in Microbiology
  • SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants, 2021, JAMA
  • Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia, 2021, Vaccine
  • Racial/Ethnic Differences in COVID-19 Vaccine Hesitancy Among Health Care Workers in 2 Large Academic Hospitals, 2021, JAMA Network Open
  • Bivalent Covid-19 Vaccines - A Cautionary Tale, 2023, New England Journal of Medicine

Prominent co-authors with whom they have collaborated include Barbara J. Kuter, Kristen A. Feemster, Safa Browne, Florence Momplaisir, and Angela K. Shen.

Paul A. Offit has also contributed to book publications, including Vaccines and Your Family published by Columbia University Press in 2024.

Throughout their career, the scientist has received various recognitions:

  • Albert B. Sabin Gold Medal, Sabin Vaccine Institute, 2018
  • Fellow of the American Association for the Advancement of Science (AAAS), 2015
  • Fellow of the American Academy of Arts and Sciences, 2015
  • Maxwell Finland Award for Scientific Achievement, National Foundation for Infectious Diseases, 2013
  • Member of the National Academy of Medicine (NAM), 2011
  • Member of the Association of American Physicians

Best Publications

  • Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine

    Timo Vesikari;David O Matson;Penelope Dennehy;Pierre Van Damme

  • Addressing Parents’ Concerns: Do Multiple Vaccines Overwhelm or Weaken the Infant’s Immune System?

    Paul A. Offit;Jessica Quarles;Michael A. Gerber;Charles J. Hackett

  • Identification of the two rotavirus genes determining neutralization specificities

    P A Offit;G Blavat

  • Vaccines and Autism: A Tale of Shifting Hypotheses

    Jeffrey S. Gerber;Paul A. Offit

  • Rotavirus isolate WI61 representing a presumptive new human serotype.

    H F Clark;Y Hoshino;L M Bell;J Groff

  • Molecular basis of rotavirus virulence: role of gene segment 4.

    P A Offit;G Blavat;H B Greenberg;H F Clark

  • Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7.

    Paul A. Offit;Robert D. Shaw;Harry B. Greenberg

  • Vaccine Safety: Myths and Misinformation.

    Sarah Geoghegan;Kevin P. O’Callaghan;Paul A. Offit

  • Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies.

    P A Offit;H F Clark

  • The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants.

    H F. Clark;P. A. Offit;R. W. Ellis;J. J. Eiden

  • Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype.

    P A Offit;H F Clark;G Blavat;H B Greenberg

  • SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants.

    John P. Moore;Paul A. Offit

  • Antigenic mapping of the surface proteins of rhesus rotavirus.

    Shaw Rd;Vo Pt;Offit Pa;Coulson Bs

  • Addressing parents' concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals?

    Paul A. Offit;Rita K. Jew

  • Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants

    H.Fred Clark;David I Bernstein;Penelope H Dennehy;Paul Offit

  • Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.

    Timo Vesikari;H Fred Clark;Paul A Offit;Michael J Dallas

  • A murine model for oral infection with a primate rotavirus (simian SA11).

    P A Offit;H F Clark;M J Kornstein;S A Plotkin

  • Rotavirus-specific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection.

    P A Offit;K I Dudzik

  • Communicating science to the public: MMR vaccine and autism

    Paul A Offit;Susan E Coffin

  • Deadly Choices: How the Anti-Vaccine Movement Threatens Us All

    Paul Offit

Frequent Co-Authors

H. Fred Clark
H. Fred Clark Children's Hospital of Philadelphia
Stanley A. Plotkin
Stanley A. Plotkin University of Pennsylvania
Harry B. Greenberg
Harry B. Greenberg Stanford University
Richard L. Ward
Richard L. Ward Cincinnati Children's Hospital Medical Center
David O. Matson
David O. Matson Eastern Virginia Medical School
John J. Treanor
John J. Treanor University of Rochester Medical Center
Steven Black
Steven Black Cincinnati Children's Hospital Medical Center
Henry R. Shinefield
Henry R. Shinefield University of California, San Francisco
Frank DeStefano
Frank DeStefano Centers for Disease Control and Prevention
Michael E. Pichichero
Michael E. Pichichero Rochester Regional Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open up diverse career opportunities. Many students often transition into nursing fields through programs like online absn programs for non nurses, designed to help non-nurses quickly gain essential nursing qualifications.

Finding the right nursing program can be challenging, but options such as accelerated nursing programs near me provide flexible paths for students eager to enter the workforce sooner. These programs can complement an Immunology background by building clinical skills.

For those seeking shorter or less competitive routes, identifying which lpn programs are easiest to get into might be a practical step. Licensed Practical Nurse (LPN) roles offer hands-on patient care and a stepping-stone to further nursing credentials.

Advanced clinical careers may involve becoming a nurse practitioner. Exploring the easiest np program can help prospective students find accessible routes to this rewarding profession, enhancing their expertise in immunology-related patient care and treatment.

Best Scientists Citing Paul A. Offit

Trending Scientists

Recently Published Articles